The Chancellor has warned there will be no alignment with EU regulations after Brexit - despite a pledge being made in the North East by Boris Johnson that standards would be protected.
Kevin Maguire: 'Soaring food prices and job losses are the reality of Boris Johnson's Brexit' 20/01/2020
Dire warnings from British industries after Chancellor Sajid Javid admitted businesses will be hit, exposes why the Prime Minister focuses on the trivial.
U.S. Lobbyists Prepare to Seize “Historic Opportunity” in Tory-Led Brexit to Shred Consumer Safeguards, Raise Drug Prices 09/12/2019
When President Donald Trump arrived in the United Kingdom this week, he landed bang in the middle of a huge political fight about the country's National Health Service.
Brian Toohey, of the Pharmaceutical Research and Manufacturers of America trade group, spearheads PhRMA and recently told of the US drugs industry's predatory intentions.
US Pharma industry lobby telling US trade negotiators that US-UK trade deal is “an important opportunity” to deal with “artificially depressed prices” in UK [1 min] 03/12/2019
This video from January is US Pharma industry lobby telling US trade negotiators that US-UK trade deal is “an important opportunity” to deal with “artificially depressed prices” in UK - “dictated” via our “primary payer” system
A US-UK trade deal is being negotiated, and drug prices are a key issue. Several US officials are demanding that foreign countries pay higher prices to US drug companies.
Post-Brexit, the cost of medicines they rely on could skyrocket.
Asked if Washington would be free to ‘jack up prices’, Foreign Secretary Dominic Raab replies ‘The Americans will take their decisions’.
How has the Leave vote affected the UK economy, ask Swati Dhingra and Thomas Sampson (LSE) in this second of two blogs based on the CEP Election Analysis briefing on Brexit.
George Hollingbery, then trade minister, and John Saville, Her Majesty’s Consul General in Chicago met a pharmaceutical company's senior director in August last year to discuss a post-Brexit pact.
Labour leader says documents leave Boris Johnson’s denials on post-Brexit US trade deal ‘in tatters’.
UK officials discussed NHS at ‘secret’ meetings with US drug companies as part of trade talks 28/10/2019
Envoys sidestep ban on discussing drug prices by referring to controversial subject ‘valuing innovation’.
Boris Johnson accused of eyeing post-Brexit US trade deal by ripping out food safeguards imposed by parliament 26/10/2019
‘This is clearly an attempt to make it harder for the public and parliament to ensure protections are not traded away’
Would food be cheaper in a no-deal Brexit? 10/10/2019
With it still possible the United Kingdom will leave the European Union without a deal, Mark Dayan looks at the impact that would have on NHS costs.
Price of X-ray machines, medicines and bedding all expected to rise, says Nuffield Trust.
Nationwide says prices in London dropped at an annual rate of 1.7% in September.
What will Brexit mean for UK dentistry? 06/04/2017
In the wake of last week’s triggering of Article 50, marking the formal start of Brexit negotiations, and the publication of the ‘Great Reform Bill’ it is a good time to ask what the effect will be on dentistry, both NHS and private.
Electricity price rises are predicted as well as major HGV hold-ups.
Parliament recall urged after Operation Yellowhammer documents warn UK may face food shortages and medicine delays 11/09/2019
Boris Johnson is facing renewed pressure to recall Parliament after the Prime Minister was forced to reveal that a no-deal Brexit could trigger medical shortages, food price rises and major cross-channel trade delays.
Supermarket chain says it may have to fly in fruit as it books extra warehouse space to stockpile goods
Operation Yellowhammer: Government no-deal Brexit documents warn of food shortages and riots 11/09/2019
Ministers have been forced to publish details of concerns about public disorder and disruption to medicine and fuel supplies.
Operation Yellowhammer documents predict public disorder, rising prices and disruptions to food and medicines.
Donald Trump is ready to use trade talks to force the National Health Service to pay more for its drugs as part of his scheme to "put American patients first”.